Prof. Dr. Seigo Kinuya: Advancing Nuclear Medicine and Theranostics in Japan
Leadership, System Development and Clinical Integration
Prof. Dr. Seigo Kinuya is one of Japan’s leading experts in nuclear medicine and theranostics. As Professor at Kanazawa University and Vice President of Kanazawa University Hospital, he has played a central role in advancing clinical nuclear medicine, molecular imaging, and radiopharmaceutical-based therapies for nearly four decades.
His expertise spans nuclear imaging, radionuclide therapy, and translational research, with a strong focus on integrating diagnostics and therapy into clinical practice. Through his work, he has contributed significantly to establishing theranostics as a key component of precision oncology in Japan.
Scientific Leadership and National Impact
Prof. Kinuya has held numerous leadership roles in academic, clinical, and governmental contexts, contributing to the development of nuclear medicine and radiopharmaceutical therapy in Japan. His work includes involvement in national initiatives related to clinical research, infrastructure development, and regulatory frameworks.
He is closely associated with institutions such as Fukushima Medical University and the Fukushima Institute for Research, Education and Innovation (F-REI), where he supports the advancement of radiation science, drug development, and next-generation theranostic approaches.
Research Excellence and International Recognition
With more than 370 peer-reviewed English-language publications indexed in PubMed, Prof. Kinuya is a highly cited contributor to the field of nuclear medicine and theranostics. His research focuses on tumor imaging, radionuclide therapy, and the development of radiopharmaceuticals for diagnostic and therapeutic applications.
His contributions have been recognized through multiple awards, including honors from the Japanese Society of Nuclear Medicine and the Best Science Paper Award from the European Journal of Nuclear Medicine.
Through international collaboration and long-standing engagement with global scientific networks, he continues to connect Japanese research with the broader theranostics community.
Shaping the Future of TWC2027
As President of the 9th Theranostics World Congress (TWC2027), Prof. Kinuya brings a unique combination of clinical expertise, academic leadership, and strategic perspective. Under his guidance, the congress will reflect both the scientific progress and the real-world challenges of implementing theranostics at scale.
TWC2027 in Osaka will further strengthen global collaboration and provide a platform for advancing Radiomolecular Precision Medicine across disciplines and regions.